Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|9|6|763-773

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.9, Iss.6, 2013-09, pp. : 763-773

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia

By Gothelf D.   Soreni N.   Nachman R.P.   Tyano S.   Hiss Y.   Reiner O.   Weizman A.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 389-395

Elsevier

Access to resources Recommend Favorite

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 219-238

Bentham Science Publishers

Access to resources Recommend Favorite

Co-Morbidity and Self Medication in Schizophrenia: Involvement of Endogenous Morphine Signaling Mechanisms

By  

Current Drug Targets, Vol. 13, Iss. 11, 2012-10 ,pp. : 1454-1457

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 1, 2002-03 ,pp. : 29-44

Bentham Science Publishers

Access to resources Recommend Favorite

Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 28, 2016-09 ,pp. : 4451-4469

Bentham Science Publishers

Access to resources Recommend Favorite